e-learning
resources
Madrid 2019
Sunday, 29.09.2019
CCC Thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mediastinal mass and Graves Disease - when is biopsy needed?
M. Matias Leitão (Coimbra, Portugal)
Source:
International Congress 2019 – CCC Thoracic oncology
Session:
CCC Thoracic oncology
Session type:
Challenging clinical cases
Number:
187
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Matias Leitão (Coimbra, Portugal). Mediastinal mass and Graves Disease - when is biopsy needed?. International Congress 2019 – CCC Thoracic oncology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Improved negative predictive value of EBUS-TBNA in isolated mediastinal / hilar lymphadenopathy: Why and what it means for patients?
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
Pediatric mediastinal disease
Source: Annual Congress 2004 - PG1 - Basics in chest imaging: the mediastinum
Year: 2004
Diagnosis of mediastinal lymphadenopathy: Clinical-radiological methods vs. mediastinoscopy
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Isolated mediastinal lymphadenopathy - How does EBUS-TBNA perform in clinical practice?
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
Features predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound in Indian setting: Is it different?
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
Ultrasound evaluation of mediastinal lymphadenopathy in patients with sarcoidosis
Source: International Congress 2014 – Different modalities and techniques for lung imaging
Year: 2014
The role of number of lymph node passes and methods of pathological examination in the adequacy specimens of EBUS-TBNA in the verification of mediastinal lymphadenopathy
Source: Annual Congress 2013 –VATS, interventional endoscopy and tracheal surgery
Year: 2013
EBUS-TBNA in sarcoidosis and lymphoma: Exploring the importance of culture on lymph nodes
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Efficacy of conventional TBNA in patients with mediastinal adenopathies - A role of cytopathologist
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015
EBUS-TBNA for the evaluation of isolated mediastinal and/or hilar lymphadenopathy (IMHL)
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?
Source: International Congress 2014 – ILDs 4
Year: 2014
How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Utility of EUS-B-FNA for the diagnosis of EBUS-TBNA inaccessible intrathoracic lesions
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
The outcome of lymph nodes previously sampled with EBUS-TBNA and deemed "inadequate" - what lessons can be learnt?
Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Year: 2013
Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014
CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Diagnostic value of cervical mediastinoscopy: Report of 506 cases
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Tuberculosis with mediastinal lymph node involvement: Current diagnostic techniques in clinical practice
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept